VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM
VYNE Therapeutics Revenue
VYNE Therapeutics reported an annual revenue of $501K, reflecting a 18.16% growth. For the quarter ending March 31, 2025, VYNE Therapeutics generated $202K in revenue.
Revenue (ttm)
501K
Revenue Growth
18.16%
Price / Sales Ratio
284.78
Revenue / Employee
38.54K
Employees
13
Market Cap
6.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|